Magnus Pedersen

788 total citations
22 papers, 570 citations indexed

About

Magnus Pedersen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Magnus Pedersen has authored 22 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Magnus Pedersen's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Magnus Pedersen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Magnus Pedersen collaborates with scholars based in Denmark, Sweden and Canada. Magnus Pedersen's co-authors include Inge Marie Svane, Marco Donia, Marie Christine Wulff Westergaard, Rikke Andersen, Troels Holz Borch, Özcan Met, Morten Nielsen, Brad H. Nelson, Katy Milne and Anders Kverneland and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Magnus Pedersen

21 papers receiving 562 citations

Peers

Magnus Pedersen
Chiara Dellepiane Italy
Elisa García-Garré Spain
Ana T. Nunes United States
Neysa Garner United States
Naoko Komura Japan
Ornella Carminati Italy
Alexander S. Dudnichenko Ukraine
Eriko Yokoi Japan
Lucia Musacchio Italy
Mark A. Glaire United Kingdom
Chiara Dellepiane Italy
Magnus Pedersen
Citations per year, relative to Magnus Pedersen Magnus Pedersen (= 1×) peers Chiara Dellepiane

Countries citing papers authored by Magnus Pedersen

Since Specialization
Citations

This map shows the geographic impact of Magnus Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Pedersen more than expected).

Fields of papers citing papers by Magnus Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Pedersen. The network helps show where Magnus Pedersen may publish in the future.

Co-authorship network of co-authors of Magnus Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Pedersen. A scholar is included among the top collaborators of Magnus Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Pedersen. Magnus Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Magnus, Niels Christian Bjerregaard, Frederik Hvid‐Jensen, & Daniel Willy Kjær. (2025). Peroral endoscopic myotomy: a Danish single center 10-year follow-up study. Surgical Endoscopy. 39(8). 4806–4814.
2.
Pedersen, Magnus, Anne Mellon Mogensen, Charlotte Aaquist Haslund, et al.. (2025). Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015–2022). European Journal of Cancer. 217. 115253–115253. 2 indexed citations
3.
4.
5.
Borch, Troels Holz, Katja Harbst, Rikke Andersen, et al.. (2021). Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma. Journal for ImmunoTherapy of Cancer. 9(7). e002703–e002703. 21 indexed citations
6.
Harbst, Katja, Troels Holz Borch, Marie Christine Wulff Westergaard, et al.. (2020). CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer. Scientific Reports. 10(1). 3914–3914. 50 indexed citations
7.
Kverneland, Anders, Magnus Pedersen, Marie Christine Wulff Westergaard, et al.. (2020). Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. Oncotarget. 11(22). 2092–2105. 77 indexed citations
8.
Westergaard, Marie Christine Wulff, Katy Milne, Magnus Pedersen, et al.. (2020). Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer. Cancers. 12(12). 3828–3828. 26 indexed citations
9.
Westergaard, Marie Christine Wulff, Rikke Andersen, Chloé Chong, et al.. (2019). Tumour-reactive T cell subsets in the microenvironment of ovarian cancer. British Journal of Cancer. 120(4). 424–434. 48 indexed citations
10.
Andersen, Rikke, Troels Holz Borch, Arianna Draghi, et al.. (2018). T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. Annals of Oncology. 29(7). 1575–1581. 51 indexed citations
11.
Pedersen, Magnus, Marie Christine Wulff Westergaard, Katy Milne, et al.. (2018). Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. OncoImmunology. 7(12). e1502905–e1502905. 89 indexed citations
12.
Pedersen, Magnus, Marie Christine Wulff Westergaard, Morten Nielsen, et al.. (2017). Adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic ovarian cancer: A pilot study. Annals of Oncology. 28. v407–v407. 11 indexed citations
13.
Donia, Marco, Magnus Pedersen, & Inge Marie Svane. (2016). Cancer immunotherapy in patients with preexisting autoimmune disorders. Seminars in Immunopathology. 39(3). 333–337. 34 indexed citations
14.
Pedersen, Magnus, Troels Holz Borch, Morten Nielsen, et al.. (2016). T cell therapy for patients with advanced ovarian cancer: a pilot study in progress. Annals of Oncology. 27. vi375–vi375. 1 indexed citations
15.
Girotti, María Romina, Gabriela Gremel, Rebecca Lee, et al.. (2016). Application of sequencing, liquid biopsies and patient-derived xenografts for personalized medicine in melanoma. European Journal of Cancer. 61. S193–S193. 1 indexed citations
16.
Andersen, Rikke, Marco Donia, Marie Christine Wulff Westergaard, et al.. (2015). Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma. Human Vaccines & Immunotherapeutics. 11(12). 2790–2795. 51 indexed citations
17.
Hansen, Lars, Magnus Pedersen, Lars Folkestad, et al.. (2015). The Stop-Only-While-Shocking algorithm reduces hands-off time by 17% during cardiopulmonary resuscitation – a simulation study. European Journal of Emergency Medicine. 23(6). 413–417. 7 indexed citations
18.
Pedersen, Magnus, Rikke Andersen, Peter Nørgaard, et al.. (2014). Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease. Cancer Immunology Immunotherapy. 63(12). 1341–1346. 48 indexed citations
19.
Pedersen, Magnus & Mikkel Brabrand. (2014). One fourth of acutely admitted patients use over-the-counter-drugs 24 hours prior to hospitalisation.. PubMed. 61(2). A4789–A4789. 4 indexed citations
20.
Pedersen, Magnus, Pål Rustad, & P. Simonsson. (2004). Certificate of analysis NFKK Reference Serum X: a reprint. Scandinavian Journal of Clinical and Laboratory Investigation. 64(4). 321–326. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Dellepiane Breakdown of academic impact, for papers by Elisa García-Garré Breakdown of academic impact, for papers by Ana T. Nunes Breakdown of academic impact, for papers by Neysa Garner Breakdown of academic impact, for papers by Naoko Komura Breakdown of academic impact, for papers by Ornella Carminati Breakdown of academic impact, for papers by Alexander S. Dudnichenko Breakdown of academic impact, for papers by Eriko Yokoi Breakdown of academic impact, for papers by Lucia Musacchio Breakdown of academic impact, for papers by Mark A. Glaire
Rankless by CCL
2026